MEN1 and metastatic neoplasm: As some studies on sporadic panNETs have demonstrated that CgA and PP can predict metastatic disease [11, 12, 22], it is possible that repeat biomarker measurement could be useful for the early detection of metastatic disease in MEN1 as well.